Researchers at Wake Forest Baptist Medical Center have shown that multi-walled carbon nanotubes injected into breast tumors and irradiated with a quick, 30-second laser beam, are effective at killing breast cancer stem cells.
Nanothermal therapy - the use of nanoparticles to cook a tumor to death - is one of the many promising uses of nanotechnology to both improve the effectiveness of cancer therapy and reduce its side effects. Now, a team of investigators from the Texas Center for Cancer Nanomedicine has shown that liver cancer cells will take up targeted gold nanoparticles, absorb radio waves, and generate heat that damages the cells.
With the aid of a novel set of lipid-coated, targeted quantum dots, researchers at Johns Hopkins University have developed a method for quantifying multiple specific biomarkers on the surfaces of individual cancer cells. This approach to quantitative biomarker detection stands to improve the histopathology methods used to diagnosis pancreatic and other cancers and enable the development of methods to spot cancer cells circulating in the blood stream.
Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that can deliver a drug directly to a cancer cell's nucleus -- an important feature for effective treatment.
By squeezing a porous solid, scientists surprisingly made its cavities open wider, letting in - and trapping - europium ions. Given the similarities between europium and uranium ions, the team, based at the University of South Carolina, Yonsei University (Korea), and Stanford University, thinks the innovation could represent a promising new avenue for nuclear waste processing.
A protocol for controlling quantum information pioneered by researchers at UC Santa Barbara, the Kavli Institute of Nanoscience in Delft, the Netherlands, and the Ames Laboratory at Iowa State University could open the door to larger-scale, more accurate quantum computations.
Nanomedicine research at the David H. Koch Institute for Integrative Cancer Research at MIT funded by a $5 million grant from the Prostate Cancer Foundation (PCF) has delivered the first nanomedicine shown to successfully target prostate cancer cells and deliver docetaxel chemotherapy in high concentrations in Phase I clinical trials.
Transforming how and where we harvest power is essential for meeting the objectives set out in the Europe 2020 strategy. One alternative energy source is printed-plastic solar technology: a new EU-funded project that has just got under way aims to advance this innovative technology, and design advanced flexible plastic solar panels that can be integrated into new consumer mobile applications and buildings.